medermycin: obtained from Streptomyces K73 [MeSH]
ID Source | ID |
---|---|
PubMed CID | 90474016 |
MeSH ID | M0060613 |
Synonym |
---|
medermycin |
60227-09-0 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 2 (8.33) | 18.7374 |
1990's | 1 (4.17) | 18.2507 |
2000's | 7 (29.17) | 29.6817 |
2010's | 9 (37.50) | 24.3611 |
2020's | 5 (20.83) | 2.80 |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 25 (100.00%) | 84.16% |
Substance | Studies | Classes | Roles | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
quinone | 1,4-benzoquinones | cofactor; human xenobiotic metabolite; mouse metabolite | 2015 | 2015 | 9.0 | low | 0 | 0 | 0 | 0 | 1 | 0 | |
azides | pseudohalide anion | mitochondrial respiratory-chain inhibitor | 2003 | 2003 | 21.0 | low | 0 | 0 | 0 | 1 | 0 | 0 | |
lactoquinomycin a | 1991 | 2002 | 25.7 | high | 0 | 0 | 1 | 2 | 0 | 0 | |||
frenolicin b | benzoisochromanequinone; p-quinones | metabolite | 2009 | 2009 | 15.0 | low | 0 | 0 | 0 | 1 | 0 | 0 | |
kalafungin | 1987 | 2015 | 20.3 | medium | 0 | 1 | 0 | 1 | 1 | 0 | |||
arabinose | L-arabinose | Escherichia coli metabolite; mouse metabolite | 2003 | 2003 | 21.0 | low | 0 | 0 | 0 | 1 | 0 | 0 | |
actinorhodin | 2003 | 2015 | 15.0 | low | 0 | 0 | 0 | 1 | 1 | 0 | |||
naphthoquinones | 1976 | 2022 | 15.0 | high | 0 | 2 | 1 | 8 | 9 | 3 | |||
cysteine | cysteinium | fundamental metabolite | 2007 | 2009 | 16.0 | low | 0 | 0 | 0 | 2 | 0 | 0 | |
interleukin-8 | 2023 | 2023 | 1.0 | low | 0 | 0 | 0 | 0 | 0 | 1 |
Condition | Indicated | Studies | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Arthritis, Degenerative | 0 | 2023 | 2023 | 1.0 | medium | 0 | 0 | 0 | 0 | 0 | 1 | |
Inflammation | 0 | 2023 | 2023 | 1.0 | medium | 0 | 0 | 0 | 0 | 0 | 1 | |
Innate Inflammatory Response | 0 | 2023 | 2023 | 1.0 | medium | 0 | 0 | 0 | 0 | 0 | 1 | |
Osteoarthritis | 0 | 2023 | 2023 | 1.0 | medium | 0 | 0 | 0 | 0 | 0 | 1 | |
Reticulum Cell-Like Sarcoma, Yoshida | 0 | 1976 | 1976 | 48.0 | medium | 0 | 1 | 0 | 0 | 0 | 0 |